SCHEMBL1829430

SCHEMBL1829430

FC1(F)OC(F)(F)C(F)(F)OC(F)(F)C(F)(F)OC(F)(F)C(F)(F)OC1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL884352 1.00
SCHEMBL4663607 1.00
SCHEMBL1829457 1.00
SCHEMBL51336 0.94
Ammonia Solution, Strong SCHEMBL9580947 0.88
SCHEMBL12502051 0.88
SCHEMBL30207737 0.78
SCHEMBL12027425 0.78
Formaldehyde SCHEMBL9794447 0.78
SCHEMBL183235 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994014415-A1 FLUOROCARBON EMULSIONS HEMAGEN/PFC (US) 1994-07-07 WO claimed
EP-2661437-B1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS CENTAURUS BIOPHARMA CO LTD (CN) 2018-11-07 EP disclosed
US-9428508-B2 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors CENTAURUS BIOPHARMA CO., LTD. (CN) 2016-08-30 US disclosed
EP-1713513-B1 CELLULAR LABELING FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES UNIV CARNEGIE MELLON (US) 2014-06-04 EP disclosed
US-20130281438-A1 2,4-DIAMINO-6,7-DIHYDRO-5H-PYRROLO[2,3]PYRIMIDINE DERIVATIVES AS FAK/Pyk2 INHIBITORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2013-10-24 US disclosed
US-8449866-B2 Cellular labeling for nuclear magnetic resonance techniques CARNEGIE MELLON UNIVERSITY (US) 2013-05-28 US disclosed
US-20130022990-A1 CELLULAR LABELING FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES CARNEGIE MELLON UNIVERSITY (US) 2013-01-24 US disclosed
US-8263043-B2 Cellular labeling and quantification for nuclear magnetic resonance techniques CARNEGIE MELLON UNIVERSITY (US) 2012-09-11 US disclosed
US-8147806-B2 Cellular labeling for nuclear magnetic resonance techniques CARNEGIE MELLON UNIVERSITY (US) 2012-04-03 US disclosed
EP-2319544-A1 Cellular labeling for nuclear magnetic resonance techniques Carnegie Mellon University (US) 2011-05-11 EP disclosed
EP-2010646-A2 CELLULAR LABELING AND QUANTIFICATION FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES Carnegie Mellon University (US) 2009-01-07 EP disclosed
US-20080292554-A1 Cellular Labeling for Nuclear Magnetic Resonance Techniques CARNEGIE MELLON UNIVERSITY (US) 2008-11-27 US disclosed
US-20070253910-A1 Cellular labeling and quantification for nuclear magnetic resonance techniques CARNEGIE MELLON UNIVERSITY (US) 2007-11-01 US disclosed
WO-2007120911-A2 CELLULAR LABELING AND QUANTIFICATION FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES CARNEGIE MELLON UNIVERSITY (US) 2007-10-25 WO disclosed
EP-1713513-A2 CELLULAR LABELING FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES CARNEGIE MELLON UNIVERSITY (US) 2006-10-25 EP disclosed
WO-2005072780-A2 CELLULAR LABELING FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES CARNEGIE MELLON UNIVERSITY (US) 2005-08-11 WO disclosed
WO-1994014415-A1 FLUOROCARBON EMULSIONS HEMAGEN/PFC (US) 1994-07-07 WO disclosed